COSCIENS BIOPHARMA INC (CSCI.CA) Stock Price, Quote, News and Overview
TSX:CSCI - Toronto Stock Exchange - CA22112H1010 - Common Stock - Currency: CAD
CSCI.CA Quote, Performance and Key Statistics
TSX:CSCI (3/7/2025, 7:00:00 PM)
3.95
-0.05 (-1.25%)
The current stock price of CSCI.CA is 3.95 CAD. In the past month the price increased by 0.51%.
CSCI.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 270.34M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 214.26M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 202.17M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 101.16M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 84.29M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 79.22M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 77.44M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 14.18 | 66.08M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 38.5 | 54.80M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 49.83M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 46.66M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 20.78M |
Related stock screener links
About CSCI.CA
Company Profile
COSCIENS Biopharma Inc is a CA-based company operating in Biotechnology industry. The company is headquartered in Toronto, Ontario. COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The firm is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
Company Info
COSCIENS BIOPHARMA INC
C/O Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53
TORONTO ONTARIO CA
Employees: 21
Company Website: https://www.zentaris.com/
Investor Relations: http://ir.aezsinc.com/
Phone: 18439003201
COSCIENS BIOPHARMA INC / CSCI.CA FAQ
What is the stock price of COSCIENS BIOPHARMA INC today?
The current stock price of CSCI.CA is 3.95 CAD. The price decreased by -1.25% in the last trading session.
What is the ticker symbol for COSCIENS BIOPHARMA INC stock?
The exchange symbol of COSCIENS BIOPHARMA INC is CSCI and it is listed on the Toronto Stock Exchange exchange.
On which exchange is CSCI.CA stock listed?
CSCI.CA stock is listed on the Toronto Stock Exchange exchange.
What is COSCIENS BIOPHARMA INC worth?
COSCIENS BIOPHARMA INC (CSCI.CA) has a market capitalization of 14.93M CAD. This makes CSCI.CA a Nano Cap stock.
How many employees does COSCIENS BIOPHARMA INC have?
COSCIENS BIOPHARMA INC (CSCI.CA) currently has 21 employees.
What are the support and resistance levels for COSCIENS BIOPHARMA INC (CSCI.CA) stock?
COSCIENS BIOPHARMA INC (CSCI.CA) has a support level at 3.95 and a resistance level at 3.99. Check the full technical report for a detailed analysis of CSCI.CA support and resistance levels.
Is COSCIENS BIOPHARMA INC (CSCI.CA) expected to grow?
The Revenue of COSCIENS BIOPHARMA INC (CSCI.CA) is expected to decline by -2.27% in the next year. Check the estimates tab for more information on the CSCI.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy COSCIENS BIOPHARMA INC (CSCI.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CSCI.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CSCI.CA, evaluating the profitability, health, valuation and growth aspects
- COSCIENS BIOPHARMA INC (CSCI.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COSCIENS BIOPHARMA INC (CSCI.CA) Sales and EPS estimates to see what analysts future expectations are.
- COSCIENS BIOPHARMA INC (CSCI.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COSCIENS BIOPHARMA INC (CSCI.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- COSCIENS BIOPHARMA INC (CSCI.CA) Stock Chart to make your own analysis
- COSCIENS BIOPHARMA INC (CSCI.CA) Latest news and press-releases to stay up to date.
Does COSCIENS BIOPHARMA INC (CSCI.CA) stock pay dividends?
CSCI.CA does not pay a dividend.
When does COSCIENS BIOPHARMA INC (CSCI.CA) report earnings?
COSCIENS BIOPHARMA INC (CSCI.CA) will report earnings on 2025-05-12.
What is the Price/Earnings (PE) ratio of COSCIENS BIOPHARMA INC (CSCI.CA)?
COSCIENS BIOPHARMA INC (CSCI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.77).
CSCI.CA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CSCI.CA.
CSCI.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CSCI.CA. While CSCI.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
CSCI.CA Financial Highlights
Over the last trailing twelve months CSCI.CA reported a non-GAAP Earnings per Share(EPS) of -15.77. The EPS decreased by -274.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.47% | ||
| ROE | -71.02% | ||
| Debt/Equity | 0.06 |
CSCI.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to CSCI.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 68.75% and a revenue growth -2.27% for CSCI.CA